Nuvectis Pharma, Inc. Basic Shares Outstanding (Weighted Average)
Nuvectis Pharma, Inc. (NVCT) reported Basic Shares Outstanding (Weighted Average) of 23.48 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 23.48M shares, a 9.87% increase year-over-year.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 23.41M shares, a 17.44% increase year-over-year.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 23.20M shares, a 30.63% increase year-over-year.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 22.72M shares, a 31.85% increase year-over-year.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 21.81M shares, a 27.46% increase from fiscal 2024.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 17.11M shares, a 10.01% increase from fiscal 2023.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 15.56M shares, a 22.90% increase from fiscal 2022.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 12.66M shares, a 196.55% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 23.48M shares 10-Q · filed 2026-08-04 | 23.45M shares 10-Q · filed 2026-08-04 | 23.36M shares derived: average of 3 quarters · filed 2026-08-04 | 23.20M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | 23.41M shares 10-Q · filed 2026-05-05 | 23.31M shares derived: average of 2 quarters · filed 2026-05-05 | 23.11M shares derived: average of 3 quarters · filed 2026-05-05 | 22.67M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | 23.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | 22.96M shares derived: average of 2 quarters · filed 2026-02-11 | 22.43M shares derived: average of 3 quarters · filed 2026-08-04 | 21.81M shares 10-K · filed 2026-02-11 | |
| 2025-09-30 | 22.72M shares 10-Q · filed 2025-11-04 | 22.04M shares derived: average of 2 quarters · filed 2026-08-04 | 21.35M shares 10-Q · filed 2025-11-04 | 20.45M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | 21.37M shares 10-Q · filed 2026-08-04 | 20.66M shares 10-Q · filed 2026-08-04 | 19.69M shares derived: average of 3 quarters · filed 2026-08-04 | 19.07M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | 19.94M shares 10-Q · filed 2026-05-05 | 18.85M shares derived: average of 2 quarters · filed 2026-05-05 | 18.31M shares derived: average of 3 quarters · filed 2026-05-05 | 17.96M shares derived: average of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | 17.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | 17.49M shares derived: average of 2 quarters · filed 2026-02-11 | 17.30M shares derived: average of 3 quarters · filed 2026-02-11 | 17.11M shares 10-K · filed 2026-02-11 | |
| 2024-09-30 | 17.23M shares 10-Q · filed 2025-11-04 | 17.07M shares derived: average of 2 quarters · filed 2025-11-04 | 16.90M shares 10-Q · filed 2025-11-04 | 16.72M shares derived: average of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | 16.90M shares 10-Q · filed 2025-08-05 | 16.73M shares 10-Q · filed 2025-08-05 | 16.55M shares derived: average of 3 quarters · filed 2025-08-05 | 16.44M shares derived: average of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | 16.56M shares 10-Q · filed 2025-05-06 | 16.38M shares derived: average of 2 quarters · filed 2025-05-06 | 16.29M shares derived: average of 3 quarters · filed 2025-05-06 | 16.01M shares derived: average of 4 quarters · filed 2025-05-06 | |
| 2023-12-31 | 16.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 16.15M shares derived: average of 2 quarters · filed 2025-02-25 | 15.83M shares derived: average of 3 quarters · filed 2025-02-25 | 15.56M shares 10-K · filed 2025-02-25 | |
| 2023-09-30 | 16.10M shares 10-Q · filed 2024-11-05 | 15.64M shares derived: average of 2 quarters · filed 2024-11-05 | 15.34M shares 10-Q · filed 2024-11-05 | 15.17M shares derived: average of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | 15.18M shares 10-Q · filed 2024-08-06 | 14.95M shares 10-Q · filed 2024-08-06 | 14.86M shares derived: average of 3 quarters · filed 2024-08-06 | 14.65M shares derived: average of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | 14.72M shares 10-Q · filed 2024-05-07 | 14.69M shares derived: average of 2 quarters · filed 2024-05-07 | 14.48M shares derived: average of 3 quarters · filed 2024-05-07 | 14.04M shares derived: average of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | 14.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 14.36M shares derived: average of 2 quarters · filed 2024-03-05 | 13.81M shares derived: average of 3 quarters · filed 2024-03-05 | 12.66M shares 10-K · filed 2024-03-05 | |
| 2022-09-30 | 14.05M shares 10-Q · filed 2023-11-08 | 13.38M shares derived: average of 2 quarters · filed 2023-11-08 | 11.99M shares 10-Q · filed 2023-11-08 | 10.11M shares derived: average of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | 12.72M shares 10-Q · filed 2023-08-09 | 10.98M shares 10-Q · filed 2023-08-09 | 10.98M shares 10-Q · filed 2022-08-10 | 8.80M shares derived: average of 3 quarters · filed 2023-08-09 | 7.72M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 9.16M shares 10-Q · filed 2023-05-10 | 6.83M shares derived: average of 2 quarters · filed 2023-05-10 | 6.06M shares derived: average of 3 quarters · filed 2023-05-10 | 5.58M shares derived: average of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | 4.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | 4.51M shares derived: average of 2 quarters · filed 2023-03-08 | 4.39M shares derived: average of 3 quarters · filed 2023-03-08 | 4.27M shares 10-K · filed 2023-03-08 | |
| 2021-09-30 | 4.51M shares 10-Q · filed 2022-11-08 | 4.33M shares derived: average of 2 quarters · filed 2022-11-08 | 4.19M shares 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | 4.16M shares 10-Q · filed 2022-08-10 | 4.03M shares 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | 3.90M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |